Kristin Wesnes

Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

Journal: NeuroImage

Published: May 11, 2026

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Journal: Neurology

Published: May 04, 2026

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Journal: Frontiers in neurology

Published: January 26, 2026

Normative Modelling of Brain Volume in Multiple Sclerosis.

Normative Modelling of Brain Volume in Multiple Sclerosis.

Journal: medRxiv : the preprint server for health sciences

Published: September 26, 2025

Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.

Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosis.

Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosis.

Journal: Scientific reports

Published: April 15, 2025

Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety.

Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety.

Journal: Multiple sclerosis and related disorders

Published: December 30, 2024

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 26, 2022

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 03, 2021

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.

Journal: European radiology

Published: June 11, 2021

Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.

Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: December 18, 2020

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 10, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026